Deep search
Search
Copilot
Images
Videos
Maps
News
Shopping
More
Flights
Travel
Hotels
Notebook
Top stories
Sports
U.S.
Local
World
Science
Technology
Entertainment
Business
More
Politics
Any time
Past hour
Past 24 hours
Past 7 days
Past 30 days
Best match
Most recent
FDA Approves 1st Non-Opioid Pain Medicine in 20 Years
FDA approves new pain medication as an alternative to opioids: What to know about Journavx
The FDA on Thursday approved a new class of pain medication that provides an alternative to opioids. It will be sold under the brand name Journavx.
FDA Approves First New Non-Opioid Pain Pill in Decades
FRIDAY, Jan. 31, 2025 (HealthDay News) -- The U.S. Food and Drug Administration (FDA) has approved Journavx, a new pain reliever without the risks of addiction or overdose linked to drugs like Vicodin and OxyContin.
FDA approves first new type of pain medication in 25 years
A new pain relief drug, suzetrigine, is a prescription pill that’s taken every 12 hours after a larger starter dose. It will be sold under the brand name Journavx.
FDA upgrades recall of Lay's potato chips
Chocolate Recall Update As FDA Sets Highest Risk Level for 9 States
A recall which was issued across nine states has now been given the highest risk classification by the federal agency.
Lay's potato chips recall upgraded to FDA's most serious level. Is Ohio affected?
The FDA elevated Lay's Classic Potato Chips to the highest risk level. Here what to know, and whether the recall impacts Ohio.
Lay's potato chips recalled over life-threatening risk as FDA issues warning
Lay recall on Lay's Classic Potato Chips across Oregon and Washington was updated to a Class 1 recall by the FDA on Thursday.
2d
on MSN
FDA approves Ozempic to reduce risks from chronic kidney disease in diabetes patients
Ozempic, the blockbuster GLP-1 drug that was originally approved to treat type 2 diabetes, has now also been approved by the ...
19h
US FDA approves Axsome Therapeutics' migraine drug
The U.S. Food and Drug Administration has approved Axsome Therapeutics' migraine treatment, the company said on Thursday.
22h
US FDA Identifies Cybersecurity Risks in Certain Patient Monitors
(Reuters) - The U.S. Food and Drug Administration (FDA) said on Thursday it had identified three cybersecurity risks ...
PCMag on MSN
56m
Chinese-Made Patient Monitor Contains a Secret Backdoor
The backdoor on Contec CMS8000 patient-monitoring devices could allow an IP address at an unnamed university to remotely ...
36m
Couple indicted for running fraudulent “full-body scan” clinics in Colorado, other states
Mary and Fred Blakley of Arizona allegedly offered veterinary medicines and unproven ultrasound procedures through a national ...
57m
on MSN
About half of Americans approve of using weight-loss drugs to treat obesity, AP-NORC poll finds
NORC Center for Public Affairs Research shows about half of U.S. adults believe it is a good thing for adults to use weight-loss drugs like Ozempic, Wegovy and other brands if they are struggling with ...
40m
on MSN
Red dye #3, banned for cancer risk, linked to behavioral problems in children
A ThedaCare pediatrician says red dye #3 can cause behaviors associated with ADHD, even in kids who don't have it.
21h
Walmart's Broccoli Recall Now Classified As Potentially Deadly, According To The FDA
In early January it was revealed that Walmart's washed and ready-to-eat 12 oz. Marketside Broccoli Florets were voluntarily ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Popular topics
# FDA
Related topics
FDA
recall
Journavx
Vertex Pharmaceuticals
Frito-Lay
Feedback